Overview
- Provides an overview of muscular dystrophy's features and treatment options
- Clinical and scientific advances are presented along with the regulatory landscape for muscular dystrophy
- Concise and practical guide for healthcare professionals, pharmaceutical executives and patient advocacy groups
Buy print copy
About this book
This practical and concise guide offers an overview of muscular dystrophy's complicated features, treatment options and general resources. New treatments and a greater understanding of proteins and structures associated with MD are discussed along with long term patient care. Also included are clinical and developmental challenges within the current regulatory landscape and recent scientific and clinical advances. Muscular Dystrophy offers clinicians, researchers, pharmaceutical executives and patient advocacy groups an easy-to-read reference that provides the necessary perspectives of the care giver and patient.
Similar content being viewed by others
Keywords
Table of contents (15 chapters)
Editors and Affiliations
About the editor
Raymond A. Huml, MS, DVM, RAC, is Executive Director, Strategic Drug Development, in the Biosimilars Center of Excellence at Quintiles. He was recently the author of the SpringerBrief, Pharmaceutical Competitive Intelligence for the Regulatory Affairs Professional. He has recruited several prominent MD's to contribute chapters to Muscular Dystrophy: A Concise Guide.
Bibliographic Information
Book Title: Muscular Dystrophy
Book Subtitle: A Concise Guide
Editors: Raymond A. Huml
DOI: https://doi.org/10.1007/978-3-319-17362-7
Publisher: Springer Cham
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer International Publishing Switzerland 2015
Softcover ISBN: 978-3-319-17361-0Published: 30 July 2015
eBook ISBN: 978-3-319-17362-7Published: 16 July 2015
Edition Number: 1
Number of Pages: XXIV, 191
Number of Illustrations: 13 b/w illustrations, 30 illustrations in colour
Topics: Neurology, Pharmacotherapy, Medicine/Public Health, general